NCT01860144Unknown不适用
An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer
Peking University1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2012年6月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 250
- 试验地点
- 1
- 主要终点
- Objective response rate
研究概览
简要总结
This observational, multicenter, prospective study will evaluate the use of bevacizumab in real clinical practice in chinese patients with metastatic colorectal cancer.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •histologically confirmed metastatic colorectal cancer patients Having initiated treatment with bevacizumab
排除标准
- •non-metastatic colorectal cancer patients not recieved bevacizumab
研究组 & 干预措施
bevacizumab
Patients with metastatic colorectal cancer who accept treatment with chemotherapy and bevacizumab
干预措施: Bevacizumab (Drug)
结局指标
主要结局
Objective response rate
时间窗: 6 weeks
To evaluate the treatment response of bevacizumab in Chinese patients with mCRC in real clinical practice
次要结局
- overall survival(3 months)
- progression free survival(6 weeks)
- resection rate(1 month)
- Proportion of patients with bevacizumab treatment discontinuation(3 weeks)
研究者
Shen Lin
Director of GI oncology
Peking University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal CancerColorectal CancerNCT01319877Hoffmann-La Roche609
Unknown
不适用
Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant ChemotherapyBevacizumabNeoadjuvant ChemotherapyMolecular Targeted TherapyBreast CancerNCT01652560LiNanlin,Ph.D, Chief Physician,Clinical Professor50
Unknown
2 期
Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung CancerMalignant Pleural EffusionNCT02942043Peking University Cancer Hospital & Institute87
已完成
不适用
An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal CancerColorectal CancerNCT01712347Hoffmann-La Roche351
已完成
不适用
Observational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNCT03170284Hoffmann-La Roche150